NextCure, Inc.NXTCNASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$-49.61M
↓ 21% vs avg
Percentile
P50
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
$-40.85M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-49.61M | -20.2% |
| 2024 | $-41.28M | +23.3% |
| 2023 | $-53.79M | +3.9% |
| 2022 | $-56.00M | +6.0% |
| 2021 | $-59.60M | -14.4% |
| 2020 | $-52.09M | -33.6% |
| 2019 | $-38.99M | -891.1% |
| 2018 | $4.93M | +123.3% |
| 2017 | $-21.17M | - |